STRS OHIO - EMERGENT BIOSOLUTIONS INC ownership

EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 197 filers reported holding EMERGENT BIOSOLUTIONS INC in Q4 2022. The put-call ratio across all filers is 0.38 and the average weighting 0.0%.

Quarter-by-quarter ownership
STRS OHIO ownership history of EMERGENT BIOSOLUTIONS INC
ValueSharesWeighting
Q1 2023$492
-20.3%
47,700
-8.8%
0.00%
-66.7%
Q4 2022$617
-99.9%
52,300
+49.0%
0.00%
-25.0%
Q3 2022$736,000
-19.0%
35,100
+19.8%
0.00%0.0%
Q2 2022$909,000
-20.3%
29,300
+5.4%
0.00%0.0%
Q1 2022$1,141,000
+11.3%
27,800
+17.8%
0.00%0.0%
Q4 2021$1,025,000
+247.5%
23,600
+300.0%
0.00%
+300.0%
Q3 2021$295,000
-74.0%
5,900
-67.2%
0.00%
-75.0%
Q2 2021$1,133,000
-85.6%
18,000
-78.7%
0.00%
-86.7%
Q1 2021$7,850,000
+8.0%
84,500
+4.2%
0.03%
+7.1%
Q4 2020$7,266,000
+5.0%
81,100
+21.0%
0.03%
-3.4%
Q3 2020$6,923,000
+105.1%
67,000
+56.9%
0.03%
+93.3%
Q2 2020$3,376,000
-23.6%
42,700
-44.1%
0.02%
-34.8%
Q1 2020$4,420,000
+2.7%
76,400
-4.3%
0.02%
+27.8%
Q4 2019$4,305,000
-39.5%
79,800
-41.4%
0.02%
+12.5%
Q3 2019$7,120,000
+50.1%
136,200
+38.7%
0.02%
-23.8%
Q2 2019$4,744,000
+12.1%
98,200
+17.2%
0.02%
+10.5%
Q1 2019$4,233,000
-11.3%
83,800
+4.1%
0.02%
-20.8%
Q4 2018$4,772,000
-22.2%
80,500
-13.6%
0.02%
-11.1%
Q3 2018$6,135,000
+15.3%
93,200
-11.6%
0.03%
+17.4%
Q2 2018$5,321,000
-0.2%
105,400
+4.0%
0.02%
-4.2%
Q1 2018$5,333,000
-2.5%
101,300
-13.9%
0.02%
+4.3%
Q4 2017$5,469,000
-12.8%
117,700
-24.1%
0.02%
-14.8%
Q3 2017$6,273,000
+4.9%
155,100
-12.1%
0.03%0.0%
Q2 2017$5,981,000
+15.2%
176,400
-1.3%
0.03%
+22.7%
Q1 2017$5,192,000
-8.0%
178,800
+4.1%
0.02%
-12.0%
Q4 2016$5,641,000
-3.1%
171,800
-6.9%
0.02%
-3.8%
Q3 2016$5,820,000
+48.0%
184,600
+32.0%
0.03%
+52.9%
Q2 2016$3,933,000
-65.7%
139,900
-55.7%
0.02%
-64.6%
Q1 2016$11,478,000
+74.5%
315,800
+92.1%
0.05%
+65.5%
Q4 2015$6,577,000
+16.3%
164,400
-17.2%
0.03%
+7.4%
Q3 2015$5,655,000
-24.9%
198,500
-13.1%
0.03%
-18.2%
Q2 2015$7,529,000
+17.5%
228,500
+2.5%
0.03%
+17.9%
Q1 2015$6,410,000
+5.2%
222,900
-0.4%
0.03%
+7.7%
Q4 2014$6,091,000
-37.1%
223,700
-50.8%
0.03%
+13.0%
Q3 2014$9,684,000
+89.0%
454,400
+99.2%
0.02%0.0%
Q2 2014$5,123,000
+507.0%
228,100
+582.9%
0.02%
+475.0%
Q1 2014$844,000
-2.3%
33,400
-11.2%
0.00%0.0%
Q4 2013$864,000
-11.6%
37,600
-26.7%
0.00%0.0%
Q3 2013$977,000
+17.0%
51,277
-11.4%
0.00%0.0%
Q2 2013$835,00057,8900.00%
Other shareholders
EMERGENT BIOSOLUTIONS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Zebra Capital Management LLC 22,111$908,0002.08%
Global Alpha Capital Management Ltd. 460,530$18,909,0001.62%
AIMZ Investment Advisors, LLC 70,625$2,900,0001.19%
Bridge City Capital, LLC 39,835$1,636,0000.76%
PALISADE CAPITAL MANAGEMENT, LP 560,409$23,010,0000.53%
EARNEST PARTNERS LLC 2,071,376$85,051,0000.50%
RICE HALL JAMES & ASSOCIATES, LLC 302,721$12,430,0000.50%
SummerHaven Investment Management, LLC 14,476$594,0000.34%
Ridgewood Investments LLC 10,004$411,0000.27%
AtonRa Partners 11,505$472,0000.26%
View complete list of EMERGENT BIOSOLUTIONS INC shareholders